
	Chemical structure search How to Search	Import MOLfile format is only available (V3000 format is not available) Exact match Substructure search Superstructure search Substructure or superstructure search Similarity search

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr

J-GLOBAL ID：202101000664564649 Update date: Jan. 31, 2025

Uehara Masahiro

ウエハラマサヒロ | Uehara Masahiro

Research field (2)： Tumor diagnostics and therapeutics , Tumor biology

Research keywords (2)： Cancer , Drug resistance

Research theme for competitive and other funds (1)：

Papers (8)：

Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, Osamu Takeuchi, Takeo Shimasaki, Tomoharu Miyashita, Toshinari Minamoto. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer. Cancer Drug Resistance. 2024
上原将大, 竹中哲, 堂本貴寛, 堀家慎一, 高橋智聡, 宮下知治, 源利成. ゲムシタビン耐性膵がんにおけるCyclin D2の過剰発現と治療標的としての可能性(Overexpression of Cyclin D2 in Gemcitabine-Resistant Pancreatic Cancer and its Potential as a Therapeutic Target). 日本癌学会総会記事. 2023. 82回. 336-336
Dilireba Bolidong, Takahiro Domoto, Masahiro Uehara, Hemragul Sabit, Tomoyuki Okumura, Yoshio Endo, Mitsutoshi Nakada, Itasu Ninomiya, Tomoharu Miyashita, Richard W. Wong, et al. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma. Scientific Reports. 2020. 10. 1. 11807-11807
Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, Dilireba Bolidong, Osamu Takeuchi, Tomoharu Miyashita, Toshinari Minamoto. Glycogen synthase kinase-3β participates in acquired resistance to gemcitabine in pancreatic cancer. Cancer Science. 2020. 111. 12. 4405-4416
Takahiro Domoto, Masahiro Uehara, Dilireba Bolidong, Toshinari Minamoto. Glycogen Synthase Kinase 3β in Cancer Biology and Treatment. Cells. 2020. 9. 6. 1388-1388

MISC (2)：

堂本貴寛, 宮下知治, DILIREBA Bolidong, 上原将大, 竹中哲, 竹中哲, 竹内修, 太田哲生, 源利成. Role of GSK3 β in malignant progression of pancreatic cancer associated with gemcitabine resistance. 日本がん転移学会学術集会・総会プログラム抄録集. 2020. 29th
Dilireba Bolidong, Takahiro Domoto, Tomoyuki Okumura, Yoshio Endo, Masahiro Uehara, Ilya V. Pyko, Tomoharu Miyashita, Toshinari Minamoto. Aberrant glycogen synthase kinase (GSK)3 beta participates in proliferation of esophageal squamous cell carcinoma (ESCC). CANCER SCIENCE. 2018. 109. 698-698

Lectures and oral presentations (14)：

Targeting Cyclin D2-Related Pathways for Overcoming Gemcitabine Resistance in Pancreatic Cancer
(2023)
Overexpression of Cyclin D2 in Gemcitabine-Resistant Pancreatic Cancer and its Potential as a Therapeutic Target
(2023)
Efficacy of preclinical GSK3β and clinical CDK4/6 inhibitors against acquired chemoresistance in pancreatic cancer
(2022)
GSK3βは膵がんのゲムシタビン獲得耐性に寄与する
(第31回日本癌病態治療研究会 2022)
Glycogen synthase kinase-3β participates in acquired resistance to gemcitabine in pancreatic cancer
(The 7th JCA-AACR Special Joint Conference: The Latest Advances in Pancreatic Cancer Research: From Basic Science to Therapeutics 2022)

Professional career (1)：

Awards (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.


	Free word	※Add the following synonyms, you can increase the number of hits.




		～